Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Hoang's Stock Ratings
Deutsche Bank Analyst
David Hoang is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
6.38%
Smart Score
Overall Average Return Percentile
49th
Number of Ratings
54
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/10/2025 | APGE | Buy Now | Apogee Therapeutics | $76.31 | 34.97% | → $103 | Initiates | → Buy | Get Alert | |
| 11/13/2025 | ALKS | Buy Now | Alkermes | $28.02 | 60.57% | $55 → $45 | Maintains | Buy | Get Alert | |
| 10/17/2025 | PRAX | Buy Now | Praxis Precision Medicine | $272.99 | 2.57% | $65 → $280 | Maintains | Buy | Get Alert | |
| 09/26/2025 | SYRE | Buy Now | Spyre Therapeutics | $33.90 | 26.84% | → $43 | Initiates | → Buy | Get Alert | |
| 09/25/2025 | HRMY | Buy Now | Harmony Biosciences Hldgs | $39.22 | -8.21% | $54 → $36 | Maintains | Buy | Get Alert | |
| 08/15/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | -43.66% | $6 → $12 | Maintains | Sell | Get Alert | |
| 07/25/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | -71.83% | $9 → $6 | Maintains | Sell | Get Alert | |
| 07/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | -57.75% | $25 → $9 | Downgrade | Hold → Sell | Get Alert | |
| 07/10/2025 | HRMY | Buy Now | Harmony Biosciences Hldgs | $39.22 | 40.23% | $54 → $55 | Maintains | Buy | Get Alert | |
| 06/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 17.37% | $50 → $25 | Maintains | Hold | Get Alert | |
| 05/21/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.92 | 30.01% | $20 → $35 | Upgrade | Hold → Buy | Get Alert | |
| 03/27/2025 | ALKS | Buy Now | Alkermes | $28.02 | 85.55% | $40 → $52 | Maintains | Buy | Get Alert | |
| 03/19/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 364.79% | $124 → $99 | Maintains | Hold | Get Alert | |
| 02/11/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $43.84 | 52.85% | → $67 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | PRAX | Buy Now | Praxis Precision Medicine | $272.99 | -59.34% | → $111 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 40.23% | → $55 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | DNLI | Buy Now | Denali Therapeutics | $17.62 | 75.94% | → $31 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | BHVN | Buy Now | Biohaven | $11.40 | 469.93% | → $65 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | AXSM | Buy Now | Axsome Therapeutics | $145.89 | 20.64% | → $176 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | ALKS | Buy Now | Alkermes | $28.02 | 42.73% | → $40 | Initiates | → Buy | Get Alert | |
| 02/11/2025 | AVDL | Buy Now | Avadel Pharmaceuticals | $21.36 | -43.82% | → $12 | Initiates | → Buy | Get Alert | |
| 08/08/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.92 | -14.56% | $30 → $23 | Maintains | Buy | Get Alert | |
| 08/08/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 651.17% | $176 → $160 | Maintains | Neutral | Get Alert | |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $152.78 | 3.42% | $150 → $158 | Maintains | Neutral | Get Alert | |
| 08/02/2024 | DNLI | Buy Now | Denali Therapeutics | $17.62 | 81.61% | $26 → $32 | Maintains | Buy | Get Alert | |
| 08/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $45 → $50 | Maintains | Buy | Get Alert | |
| 07/25/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.14 | 227.1% | → $7 | Initiates | → Buy | Get Alert | |
| 07/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $40 → $45 | Maintains | Buy | Get Alert | |
| 06/26/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 726.29% | $172 → $176 | Downgrade | Buy → Neutral | Get Alert | |
| 06/21/2024 | HRMY | Buy Now | Harmony Biosciences | $39.22 | 22.39% | → $48 | Initiates | → Buy | Get Alert | |
| 05/29/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | → $8 | Initiates | → Sell | Get Alert | |
| 05/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $43.84 | 36.88% | $62 → $60 | Maintains | Buy | Get Alert | |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.92 | 11.44% | $30.19 → $30 | Maintains | Buy | Get Alert | |
| 05/07/2024 | AXSM | Buy Now | Axsome Therapeutics | $145.89 | -14.32% | $127 → $125 | Maintains | Buy | Get Alert | |
| 05/03/2024 | NBIX | Buy Now | Neurocrine Biosciences | $152.78 | -1.82% | $140 → $150 | Maintains | Neutral | Get Alert | |
| 03/26/2024 | AXSM | Buy Now | Axsome Therapeutics | $145.89 | -12.95% | $125 → $127 | Maintains | Buy | Get Alert | |
| 03/15/2024 | SLDB | Buy Now | Solid Biosciences | $5.76 | 177.78% | → $16 | Initiates | → Buy | Get Alert | |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.92 | 12.15% | $38 → $30.19 | Maintains | Buy | Get Alert | |
| 03/07/2024 | VYGR | Buy Now | Voyager Therapeutics | $4.33 | 269.52% | → $16 | Initiates | → Buy | Get Alert | |
| 02/29/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 707.51% | $160 → $172 | Maintains | Buy | Get Alert | |
| 02/16/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $40 | Initiates | → Buy | Get Alert | |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $152.78 | -8.36% | $141 → $140 | Maintains | Neutral | Get Alert | |
| 01/04/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $43.84 | 41.44% | → $62 | Initiates | → Buy | Get Alert | |
| 12/13/2023 | DNLI | Buy Now | Denali Therapeutics | $17.62 | 81.61% | → $32 | Initiates | → Buy | Get Alert | |
| 12/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $152.78 | -16.87% | → $127 | Initiates | → Neutral | Get Alert | |
| 12/13/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.92 | 41.16% | → $38 | Initiates | → Buy | Get Alert | |
| 12/13/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 430.52% | → $113 | Initiates | → Buy | Get Alert | |
| 12/13/2023 | AXSM | Buy Now | Axsome Therapeutics | $145.89 | -14.32% | → $125 | Initiates | → Buy | Get Alert | |
| 04/26/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $398.28 | -44.76% | → $220 | Initiates | → Neutral | Get Alert | |
| 04/26/2023 | ARWR | Buy Now | Arrowhead Pharma | $68.75 | 16.36% | → $80 | Initiates | → Outperform | Get Alert | |
| 04/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.30 | 768.54% | → $185 | Initiates | → Outperform | Get Alert | |
| 03/14/2023 | PRVB | Buy Now | Provention Bio | — | — | $15 → $25 | Downgrade | Outperform → Neutral | Get Alert | |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $3.71 | -19.14% | → $3 | Downgrade | Outperform → Neutral | Get Alert | |
| 04/01/2022 | ORTX | Buy Now | Orchard Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved